08:00 , Feb 11, 2016 |  BC Innovations  |  Targets & Mechanisms

Complementary ideas

A Harvard team has mapped one of the strongest, and most difficult to decipher, genetic risk factors for schizophrenia to C4a, a molecule involved in the complement cascade. While the results offer a new therapeutic...
07:00 , May 4, 2009 |  BioCentury  |  Emerging Company Profile

InflaRX: Safety in Sepsis

Xigris drotrecogin alfa is the only drug approved to treat sepsis, but a narrow label and bleeding risks have limited its use to severely septic patients at high risk of death. InflaRx GmbH believes its...